Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine

• Published in: JAAD Case Reports Vol. 24; pp. 101 - 104
• Main Authors: Han, Joseph, Russo, Gerardo, Stratman, Scott, Psomadakis, Corinna E., Rigo, Rachel, Owji, Shayan, Luu, Yen, Mubasher, Adnan, Gonzalez, Belen Rubio, Ungar, Jonathan, Harp, Joanna, Magro, Cynthia, Ungar, Benjamin, Lamb, Angela, Gulati, Nicholas
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2022; Elsevier
• Subjects: Case Report; corticosteroids; COVID-19 booster; COVID-19 vaccine; drug reaction; drug-induced linear IgA disease; linear IgA bullous dermatosis; Moderna; terbinafine; toxic epidermal necrolysis; toxic epidermal necrolysis-like linear IgA bullous dermatosis; drug-induced linear IgA disease; terbinafine; DILAD; toxic epidermal necrolysis; corticosteroids; COVID-19 booster; LABD; Moderna; COVID-19 vaccine; drug reaction; toxic epidermal necrolysis-like linear IgA bullous dermatosis; TEN; linear IgA bullous dermatosis; ED; LABD, linear IgA bullous dermatosis; TEN, toxic epidermal necrolysis; DILAD, drug-induced linear IgA disease; ED, emergency department
• ISSN: 2352-5126; 2352-5126
• DOI: 10.1016/j.jdcr.2022.04.021